| Original language | English |
|---|---|
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | PharmacoEconomics |
| Volume | 32 |
| Issue number | 1 |
| Early online date | 28 Nov 2013 |
| DOIs | |
| Publication status | Published - Jan 2014 |
| Externally published | Yes |
Why should regulators consider using patient preferences in benefit-risk assessment?
Janine A. Van Til*, Maarten J. IJzerman
*Corresponding author for this work
Research output: Contribution to journal › Editorial › Academic › peer-review
